ClinicalTrials.gov
public full text
Public Domain
A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD
This study aims to examine the retention rate of secukinumab in adult patients with plaque psoriasis (with or without psoriatic arthritis \[PsA\]) and metabolic dysfunction-associated steatotic liver disease (MASLD) in routine clinical practice in Spain, as well as hepatic biomarker trajectories. The study will use electronic medical record (EMR) data from multiple Spanish hospitals.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical Effects of New Approach on Patients With Non-alcoholic Steatohepatitis#881547
- Study Evaluating Workload, Clinical and Therapeutic Management of Psoriatic Arthritis#862493
- A Study of Early Secukinumab Treatment in Moderate to Severe Hidradenitis Suppurativa Patients#848996
- Study of Secukinumab Compared to Fumaderm® in Adults With Moderate to Severe Psoriasis.#888454
- A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis#1111392
Record · ID 884891
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive